Human Chorionic Gonadotropin Growth Forecast 2025-2034: Trends, Opportunities, and Key Insights You Need to Know
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What is the Predicted CAGR for the Human Chorionic Gonadotropin Market Over the Forecast Period of 2025 to 2034?
The market size for human chorionic gonadotropin has seen robust growth in the previous years. The market is projected to expand from $0.95 billion in 2024 to $1.03 billion in 2025, with an impressive compound annual growth rate (CAGR) of 8.7%. Factors such as the increasing incidence of hypogonadism in the elderly population, heightened awareness of HCG amongst medical professionals and patients, the growing preference for fertility tourism, a rise in the aged population, and enhancements in health facilities coupled with increased affordability have contributed to the market’s historical growth.
In the coming years, the market size of human chorionic gonadotropin is predicted to experience vigorous growth. It is projected that by 2029, the market will surge to $1.42 billion with a compound annual growth rate (CAGR) of 8.4%. The growth during the forecast period can be linked to the growing cases of infertility, the escalating prevalence of polycystic ovary syndrome, a rise in female infertility, and increased usage of HCG in the field of veterinary medicine. The forecast period is also expected to see major trends such as progress in the detection of pregnancy, inventive drug formulations, integration of technology, emphasis on research and innovation, and product innovation.
Which Factors Are Enhancing the Growth of the Human Chorionic Gonadotropin Market?
The human chorionic gonadotropin market is expected to be propelled by a rising infertility rate. Infertility is defined as the incapacity to get pregnant after at least one year of regular, unprotected sexual activity. Factors such as delayed child-bearing, changes in lifestyle, environmental influences, and health conditions contribute to an increased prevalence of individuals and couples struggling to conceive. Human chorionic gonadotropin, or hCG, is a significant part of infertility treatments as it promotes ovulation in women and boosts testosterone production in men, which aids in the release of eggs, thus enhancing fertility results. For instance, data from the World Health Organization in April 2023, a Switzerland-based intergovernmental organization, revealed that about 17.5% of the global adult population, or roughly one out of every six people worldwide, were impacted by infertility. This underscores the urgent requirement for affordable, superior quality fertility care for those affected. Consequently, the growing rate of infertility is spurring the expansion of the human chorionic gonadotropin market.
Get Your Free Sample of the Global Human Chorionic Gonadotropin Market Report Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=18638&type=smp
Who Are the Top Companies Driving Innovation and Growth in the Human Chorionic Gonadotropin Market?
Major companies operating in the human chorionic gonadotropin market are:
• Pfizer Inc._x000D_
• Merck & Co Inc._x000D_
• Novartis AG_x000D_
• Bristol-Myers Squibb Company_x000D_
• Fresenius Kabi AG_x000D_
What Key Trends Are Currently Impacting the Human Chorionic Gonadotropin Market’s Development?
Leading businesses in the market for human chorionic gonadotropin are concentrating on the creation of novel products including pregnancy detection kits, with the aim of boosting diagnostic precision, enhancing patient results, and broadening their market presence. Pregnancy detection kits serve as devices that confirm pregnancy by identifying human chorionic gonadotropin (hCG) in the body. For example, in June 2022, Proov, a medical equipment manufacturer based in the US, introduced new hCG tests designed specifically for the early detection of pregnancy, which allows women to confirm their pregnancy up to six days prior to their estimated period. These tests work by detecting the existence of human chorionic gonadotropin (hCG) in the urine and provide high precision, with a trustworthiness rate of over 99. This development aims to offer women a reliable and accessible way to check their pregnancy status sooner than conventional tests, enabling them to make educated decisions about their reproductive wellbeing.
Get Instant Access to the Global Human Chorionic Gonadotropin Market Report with Swift Delivery!
https://www.thebusinessresearchcompany.com/report/human-chorionic-gonadotropin-global-market-report
What Are the Major Segments of the Human Chorionic Gonadotropin Market and Their Role in Driving Growth?
The human chorionic gonadotropin market covered in this report is segmented –
1) By Technology: Natural Source Extraction, Recombinant Technology
2) By Therapeutic Area: Female Infertility Treatment, Oligospermic Treatment, Male Hypogonadism, Other Therapeutic Areas
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
4) By End User: Fertility Clinics, Research Institutions, Other End Users
Subsegments:
1) By Natural Source Extraction: Extraction From Pregnant Women’s Urine, Extraction From Animal Sources
2) By Recombinant Technology: Recombinant Hcg, Recombinant Hcg For Therapeutic Use, Recombinant Hcg For Diagnostic Applications
Which Geographical Regions Are Pioneering Growth in the Human Chorionic Gonadotropin Market?
North America was the largest region in the human chorionic gonadotropin market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human chorionic gonadotropin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Key Characteristics That Define the Human Chorionic Gonadotropin Market?
Human chorionic gonadotropin (hCG) is a hormone produced during pregnancy. It is produced by the placenta shortly after the embryo implants in the uterus. hCG plays a critical role in maintaining pregnancy by stimulating the corpus luteum (a structure in the ovary) to produce progesterone, which supports the uterine lining and prevents it from breaking down.
Browse Through More Similar Reports By The Business Research Company:
Mineral And Bone Disorder Treatment Global Market Report 2024
Anorectal Disorders Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/anorectal-disorders-treatment-global-market-report
Cleanroom Technology Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cleanroom-technology-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
